|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-11-13
|
|
pubmed:abstractText |
To compare the clinical and microbiological outcome of a single-dose administration of cefuroxime or combined piperacillin/tazobactam (PT) after transrectal prostatic core-biopsy (TPB) in a prospective, randomized, open-label study.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0007-1331
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
351-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7551845-Aged,
pubmed-meshheading:7551845-Bacterial Infections,
pubmed-meshheading:7551845-Biopsy, Needle,
pubmed-meshheading:7551845-Cefuroxime,
pubmed-meshheading:7551845-Drug Therapy, Combination,
pubmed-meshheading:7551845-Humans,
pubmed-meshheading:7551845-Injections, Intravenous,
pubmed-meshheading:7551845-Male,
pubmed-meshheading:7551845-Penicillanic Acid,
pubmed-meshheading:7551845-Piperacillin,
pubmed-meshheading:7551845-Prospective Studies,
pubmed-meshheading:7551845-Prostate,
pubmed-meshheading:7551845-Prostatic Neoplasms,
pubmed-meshheading:7551845-beta-Lactamases
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam.
|
|
pubmed:affiliation |
Bristol Urological Institute, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
